• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在纯化的人巨细胞病毒中存在一种46千道尔顿的多肽,它具有脱氧核糖核酸酶活性,并且在抗原性上与一种分子量更高、无酶活性的细胞蛋白相关。

A 46 KD polypeptide, present in purified human cytomegalovirus, is provided with DNase activity and is antigenically related to a higher molecular weight, enzymatically inactive, cellular protein.

作者信息

Ripalti A, Landini M P, La Placa M

机构信息

Institute of Microbiology, University of Bologna, Medical Faculty, Italy.

出版信息

Microbiologica. 1988 Jan;11(1):69-76.

PMID:2832711
Abstract

DNase activity can be detected in lysates of extensively purified human cytomegalovirus (HCMV) particles. The presence of activity only in purified virions and not in dense bodies and its neutralization by HCMV-positive human sera strongly suggest that the enzyme is virus-specific. In situ analysis of the enzymatic activity of individual HCMV polypeptides, separated in a DNA-containing polyacrylamide gel, has shown that the DNase activity present in purified virions is mainly associated with a polypeptide of 46,000 dalton MW (p46). A monospecific anti-p46 serum, raised in mice, neutralizes about 80% of the DNase activity present in extracts of purified virions and recognizes an enzymatically inactive, 76,000 dalton MW polypeptide both in non-infected and HCMV-infected cells.

摘要

在广泛纯化的人巨细胞病毒(HCMV)颗粒的裂解物中可检测到脱氧核糖核酸酶(DNase)活性。仅在纯化的病毒粒子中存在该活性,而在致密体中不存在,并且其被HCMV阳性人血清中和,这强烈表明该酶是病毒特异性的。对在含DNA的聚丙烯酰胺凝胶中分离的单个HCMV多肽的酶活性进行原位分析表明,纯化病毒粒子中存在的DNase活性主要与分子量为46,000道尔顿(p46)的多肽相关。在小鼠中产生的单特异性抗p46血清可中和纯化病毒粒子提取物中约80%的DNase活性,并在未感染和HCMV感染的细胞中识别出一种无酶活性、分子量为76,000道尔顿的多肽。

相似文献

1
A 46 KD polypeptide, present in purified human cytomegalovirus, is provided with DNase activity and is antigenically related to a higher molecular weight, enzymatically inactive, cellular protein.在纯化的人巨细胞病毒中存在一种46千道尔顿的多肽,它具有脱氧核糖核酸酶活性,并且在抗原性上与一种分子量更高、无酶活性的细胞蛋白相关。
Microbiologica. 1988 Jan;11(1):69-76.
2
Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus.人巨细胞病毒病毒体、无感染性包膜颗粒和致密体的磷蛋白及蛋白激酶活性特征
J Virol. 1986 Sep;59(3):714-27. doi: 10.1128/JVI.59.3.714-727.1986.
3
Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.人类巨细胞病毒糖蛋白B的功能:组成性表达gB的细胞中的合胞体形成被病毒中和抗体阻断。
Virology. 1994 Jun;201(2):263-76. doi: 10.1006/viro.1994.1291.
4
Detection of a precursor of bovine leukemia virus structural proteins in purified virions.在纯化病毒粒子中检测牛白血病病毒结构蛋白的前体
Ann Rech Vet. 1978;9(4):619-26.
5
Replication of human cytomegalovirus in human retinal glial cells.人巨细胞病毒在人视网膜神经胶质细胞中的复制
Invest Ophthalmol Vis Sci. 1996 Sep;37(10):1957-66.
6
Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting.
J Med Virol. 1985 Dec;17(4):303-11. doi: 10.1002/jmv.1890170403.
7
A 28000 molecular weight human cytomegalovirus structural polypeptide studied by means of a specific monoclonal antibody.利用特异性单克隆抗体研究的一种分子量为28000的人巨细胞病毒结构多肽。
J Gen Virol. 1985 Nov;66 ( Pt 11):2507-11. doi: 10.1099/0022-1317-66-11-2507.
8
Human antibody response to human cytomegalovirus-specific DNA-binding proteins.人类对人巨细胞病毒特异性DNA结合蛋白的抗体反应。
Acta Virol. 1988 Jan;32(1):1-5.
9
Structural and immunological characterization of the intracellular forms of an abundant 68,000 Mr human cytomegalovirus protein.
J Gen Virol. 1987 Jul;68 ( Pt 7):1897-907. doi: 10.1099/0022-1317-68-7-1897.
10
Characterization of a 52K protein of murine cytomegalovirus and its immunological cross-reactivity with the DNA-binding protein ICP36 of human cytomegalovirus.小鼠巨细胞病毒52K蛋白的特性及其与人巨细胞病毒DNA结合蛋白ICP36的免疫交叉反应性。
J Gen Virol. 1991 Jun;72 ( Pt 6):1421-7. doi: 10.1099/0022-1317-72-6-1421.